| Mark D Michitsch, OD | |
|
9700 South Mccarran Blvd, Reno, NV 89523 | |
| (775) 827-3937 | |
| (775) 746-5316 |
| Full Name | Mark D Michitsch |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 36 Years |
| Location | 9700 South Mccarran Blvd, Reno, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043249394 | NPI | - | NPPES |
| 1043249394 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 278 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rowan Optometry Pc | 7719318781 | 14 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
Drs. Savita Khanna and Cameron Rink, both assistant professors of surgery in the College of Medicine at The Ohio State University Medical Center are part of a research team that has been working for more than a decade to identify ways to reduce brain injury during stroke.
The Federation of State Medical Boards (FSMB) announced the recipients of its 2013 awards recognizing outstanding service and leadership in the field of medical regulation.
After earning hundreds of millions of dollars through Medicare incentive programs designed to improve the quality of care and hold down costs, the medical profession now worries about the flip side of bonuses -; financial penalties from all angles.
The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called "latent" tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.
› Verified 2 days ago
| Provider Name | Rowan Optometry Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780233460 PECOS PAC ID: 7719318781 Enrollment ID: O20200506001466 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
Drs. Savita Khanna and Cameron Rink, both assistant professors of surgery in the College of Medicine at The Ohio State University Medical Center are part of a research team that has been working for more than a decade to identify ways to reduce brain injury during stroke.
The Federation of State Medical Boards (FSMB) announced the recipients of its 2013 awards recognizing outstanding service and leadership in the field of medical regulation.
After earning hundreds of millions of dollars through Medicare incentive programs designed to improve the quality of care and hold down costs, the medical profession now worries about the flip side of bonuses -; financial penalties from all angles.
The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called "latent" tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark D Michitsch, OD 3333 Quality Dr, Rancho Cordova, CA 95670-7985 Ph: (614) 784-5331 | Mark D Michitsch, OD 9700 South Mccarran Blvd, Reno, NV 89523 Ph: (775) 827-3937 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
Drs. Savita Khanna and Cameron Rink, both assistant professors of surgery in the College of Medicine at The Ohio State University Medical Center are part of a research team that has been working for more than a decade to identify ways to reduce brain injury during stroke.
The Federation of State Medical Boards (FSMB) announced the recipients of its 2013 awards recognizing outstanding service and leadership in the field of medical regulation.
After earning hundreds of millions of dollars through Medicare incentive programs designed to improve the quality of care and hold down costs, the medical profession now worries about the flip side of bonuses -; financial penalties from all angles.
The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called "latent" tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.
› Verified 2 days ago
Jeffrey D. Ferris, O.d., P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5595 S. Virginia St., Suite B, Reno, NV 89502 Phone: 775-828-2300 | |
Dr. Richard Andrew Boren, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6360 Mae Anne Ave., Suite 1, Reno, NV 89523 Phone: 772-787-9137 Fax: 775-323-3652 | |
Dr. Troy Robert Ogden, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 236 W. 6th St, Suite 100, Reno, NV 89503 Phone: 775-322-4061 Fax: 775-322-6603 | |
Family Eyecare Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 18601 Wedge Pkwy, Reno, NV 89511 Phone: 775-358-1020 | |
Kopolow & Girisgen Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13921 S Virginia St Ste 116, Reno, NV 89511 Phone: 702-341-7254 | |
Optic Gallery South Meadows Llc Optometrist Medicare: Medicare Enrolled Practice Location: 770 S Meadows Pkwy Ste 108&109, Reno, NV 89521 Phone: 775-224-4543 | |
Dr. David Hubbard, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10459 Double R Blvd, Reno, NV 89521 Phone: 775-827-3030 Fax: 775-827-5479 |